But if you look at pharmaceuticals as a percentage of GDP, it's cheaper for Australians to pay for the PBS through tax than for pharmaceuticals to be bought directly. That's because the Commonwealth has enormous purchasing power. It can and does alter the bottom line of multinationals by tens or hundreds of millions of dollars by including or excluding drugs from the scheme.